Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
Objective To analyse the role of multibiomarker disease activity (MBDA) score in predicting disease relapses in patients with rheumatoid arthritis (RA) in sustained remission who tapered disease modifying antirheumatic drug (DMARD) therapy in RETRO, a prospective randomised controlled trial. - Metho...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[2016]
|
| In: |
Annals of the rheumatic diseases
Year: 2015, Volume: 75, Issue: 9, Pages: 1637-1644 |
| ISSN: | 1468-2060 |
| DOI: | 10.1136/annrheumdis-2015-207900 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/annrheumdis-2015-207900 Verlag, lizenzpflichtig, Volltext: https://ard.bmj.com/content/75/9/1637 
|
| Author Notes: | Juergen Rech, Axel J. Hueber, Stephanie Finzel, Matthias Englbrecht, Judith Haschka, Bernhard Manger, Arnd Kleyer, Michaela Reiser, Jayme Fogagnolo Cobra, Camille Figueiredo, Hans-Peter Tony, Stefan Kleinert, Joerg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hanns-Martin Lorenz, Hubert Nuesslein, Rieke Alten, Joerg Henes, Klaus Krueger, Georg Schett |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 170073573X | ||
| 003 | DE-627 | ||
| 005 | 20230426062200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200617r20162015xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/annrheumdis-2015-207900 |2 doi | |
| 035 | |a (DE-627)170073573X | ||
| 035 | |a (DE-599)KXP170073573X | ||
| 035 | |a (OCoLC)1341339793 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Rech, Jürgen |e VerfasserIn |0 (DE-588)121212667X |0 (DE-627)1700736612 |4 aut | |
| 245 | 1 | 0 | |a Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment |c Juergen Rech, Axel J. Hueber, Stephanie Finzel, Matthias Englbrecht, Judith Haschka, Bernhard Manger, Arnd Kleyer, Michaela Reiser, Jayme Fogagnolo Cobra, Camille Figueiredo, Hans-Peter Tony, Stefan Kleinert, Joerg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hanns-Martin Lorenz, Hubert Nuesslein, Rieke Alten, Joerg Henes, Klaus Krueger, Georg Schett |
| 264 | 1 | |c [2016] | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online first 19 October 2015 | ||
| 500 | |a Gesehen am 17.06.2020 | ||
| 520 | |a Objective To analyse the role of multibiomarker disease activity (MBDA) score in predicting disease relapses in patients with rheumatoid arthritis (RA) in sustained remission who tapered disease modifying antirheumatic drug (DMARD) therapy in RETRO, a prospective randomised controlled trial. - Methods MBDA scores (scale 1-100) were determined based on 12 inflammation markers in baseline serum samples from 94 patients of the RETRO study. MBDA scores were compared between patients relapsing or remaining in remission when tapering DMARDs. Demographic and disease-specific parameters were included in multivariate logistic regression analysis for defining predictors of relapse. - Results Moderate-to-high MBDA scores were found in 33% of patients with RA overall. Twice as many patients who relapsed (58%) had moderate/high MBDA compared with patients who remained in remission (21%). Baseline MBDA scores were significantly higher in patients with RA who were relapsing than those remaining in stable remission (N=94; p=0.0001) and those tapering/stopping (N=59; p=0.0001). Multivariate regression analysis identified MBDA scores as independent predictor for relapses in addition to anticitrullinated protein antibody (ACPA) status. Relapse rates were low (13%) in patients who were MBDA−/ACPA−, moderate in patients who were MBDA+/ACPA− (33.3%) and MBDA−ACPA+ (31.8%) and high in patients who were MBDA+/ACPA+ (76.4%). - Conclusions MBDA improved the prediction of relapses in patients with RA in stable remission undergoing DMARD tapering. If combined with ACPA testing, MBDA allowed prediction of relapse in more than 80% of the patients. - Trial registration number EudraCT 2009-015740-42. | ||
| 534 | |c 2015 | ||
| 700 | 1 | |a Hueber, Axel J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Finzel, Stephanie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Englbrecht, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haschka, Judith |e VerfasserIn |4 aut | |
| 700 | 1 | |a Manger, Bernhard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kleyer, Arnd |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reiser, Michaela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cobra, Jayme Fogagnolo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Figueiredo, Camille |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tony, Hans-Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kleinert, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wendler, Joerg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schuch, Florian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ronneberger, Monika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Feuchtenberger, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fleck, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Manger, Karin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ochs, Wolfgang |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitt-Haendle, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lorenz, Hanns-Martin |d 1962- |e VerfasserIn |0 (DE-588)112253865 |0 (DE-627)627277845 |0 (DE-576)167601369 |4 aut | |
| 700 | 1 | |a Nuesslein, Hubert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alten, Rieke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Henes, Joerg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krueger, Klaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schett, Georg |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d [Amsterdam] : Elsevier, 1939 |g 75(2016), 9, Seite 1637-1644 |w (DE-627)300184999 |w (DE-600)1481557-6 |w (DE-576)078941237 |x 1468-2060 |7 nnas |a Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment |
| 773 | 1 | 8 | |g volume:75 |g year:2016 |g number:9 |g pages:1637-1644 |g extent:8 |a Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1136/annrheumdis-2015-207900 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://ard.bmj.com/content/75/9/1637 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200617 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 112253865 |a Lorenz, Hanns-Martin |m 112253865:Lorenz, Hanns-Martin |d 910000 |d 910100 |e 910000PL112253865 |e 910100PL112253865 |k 0/910000/ |k 1/910000/910100/ |p 21 | ||
| 999 | |a KXP-PPN170073573X |e 3687754979 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"8 S.","noteIll":"Diagramme"}],"person":[{"role":"aut","given":"Jürgen","display":"Rech, Jürgen","family":"Rech"},{"given":"Axel J.","family":"Hueber","display":"Hueber, Axel J.","role":"aut"},{"role":"aut","display":"Finzel, Stephanie","family":"Finzel","given":"Stephanie"},{"role":"aut","display":"Englbrecht, Matthias","family":"Englbrecht","given":"Matthias"},{"given":"Judith","family":"Haschka","display":"Haschka, Judith","role":"aut"},{"given":"Bernhard","display":"Manger, Bernhard","family":"Manger","role":"aut"},{"role":"aut","given":"Arnd","family":"Kleyer","display":"Kleyer, Arnd"},{"role":"aut","given":"Michaela","display":"Reiser, Michaela","family":"Reiser"},{"given":"Jayme Fogagnolo","family":"Cobra","display":"Cobra, Jayme Fogagnolo","role":"aut"},{"family":"Figueiredo","display":"Figueiredo, Camille","given":"Camille","role":"aut"},{"given":"Hans-Peter","family":"Tony","display":"Tony, Hans-Peter","role":"aut"},{"role":"aut","display":"Kleinert, Stefan","family":"Kleinert","given":"Stefan"},{"given":"Joerg","family":"Wendler","display":"Wendler, Joerg","role":"aut"},{"role":"aut","display":"Schuch, Florian","family":"Schuch","given":"Florian"},{"display":"Ronneberger, Monika","family":"Ronneberger","given":"Monika","role":"aut"},{"role":"aut","given":"Martin","family":"Feuchtenberger","display":"Feuchtenberger, Martin"},{"role":"aut","given":"Martin","display":"Fleck, Martin","family":"Fleck"},{"display":"Manger, Karin","family":"Manger","given":"Karin","role":"aut"},{"role":"aut","family":"Ochs","display":"Ochs, Wolfgang","given":"Wolfgang"},{"role":"aut","family":"Schmitt-Haendle","display":"Schmitt-Haendle, Matthias","given":"Matthias"},{"role":"aut","family":"Lorenz","display":"Lorenz, Hanns-Martin","given":"Hanns-Martin"},{"role":"aut","given":"Hubert","display":"Nuesslein, Hubert","family":"Nuesslein"},{"role":"aut","given":"Rieke","display":"Alten, Rieke","family":"Alten"},{"role":"aut","family":"Henes","display":"Henes, Joerg","given":"Joerg"},{"display":"Krueger, Klaus","family":"Krueger","given":"Klaus","role":"aut"},{"display":"Schett, Georg","family":"Schett","given":"Georg","role":"aut"}],"title":[{"title":"Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment","title_sort":"Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment"}],"relHost":[{"id":{"zdb":["1481557-6"],"issn":["1468-2060"],"eki":["300184999"]},"corporate":[{"role":"isb","display":"European League against Rheumatism"},{"display":"British Medical Association","role":"isb"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"8","year":"2016","issue":"9","volume":"75","text":"75(2016), 9, Seite 1637-1644","pages":"1637-1644"},"titleAlt":[{"title":"ARD"}],"title":[{"subtitle":"the EULAR journal","title":"Annals of the rheumatic diseases","title_sort":"Annals of the rheumatic diseases"}],"origin":[{"publisher":"Elsevier ; BMJ Publ. Group","dateIssuedKey":"2025","dateIssuedDisp":"2025-","publisherPlace":"[Amsterdam] ; London"}],"pubHistory":["1.1939 -"],"note":["Gesehen am 24.01.2025","Beteil. Urh. teils: British Medical Association"],"recId":"300184999","name":{"displayForm":["European Alliance of Associations for Rheumatology (EULAR)"]},"disp":"Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentAnnals of the rheumatic diseases"}],"language":["eng"],"id":{"eki":["170073573X"],"doi":["10.1136/annrheumdis-2015-207900"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"[2016]"}],"name":{"displayForm":["Juergen Rech, Axel J. Hueber, Stephanie Finzel, Matthias Englbrecht, Judith Haschka, Bernhard Manger, Arnd Kleyer, Michaela Reiser, Jayme Fogagnolo Cobra, Camille Figueiredo, Hans-Peter Tony, Stefan Kleinert, Joerg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hanns-Martin Lorenz, Hubert Nuesslein, Rieke Alten, Joerg Henes, Klaus Krueger, Georg Schett"]},"note":["Published online first 19 October 2015","Gesehen am 17.06.2020"],"recId":"170073573X"} | ||
| SRT | |a RECHJUERGEPREDICTION2016 | ||